Oncology Times | July 10 2016 Vol.38 Issue 13 | NursingCenter

Oncology Times

July 10 2016 Volume : 38 Issue Number : 13

Oncology Times

About This Publication

NCPD from this Journal

Subscribe to current issue RSS feed

<< Previous Issue

Featured Articles

Buy

Dexamethasone vs. Prednisone in Acute Lymphoblastic Leukemia
Robert H. Carlson
Buy

Implementation of MACRA Physician Payment Rule Challenging
Peggy Eastman
Buy

Measuring Hospitals' Long-Term Cancer Care Outcomes
David Pfister MD
Buy

PhRMA CEO Hails Progress in Targeted Therapies, Decries Regulations
Peggy Eastman

Departments

Free

3 Questions on...The Problem With Clinical Trial Enrollment: With PAUL SABBATINI, MD, Deputy Physician-in-Chief for Clinical Research at Memorial Sloan Kettering Cancer Center
Sarah DiGiulio
Free

ABVD, BEACOPP Show Similar Survival But Different Toxicities
Robert H. Carlson
Free

Atezolizumab Shows First-line Activity in Advanced Bladder Cancer
Mark L. Fuerst
Free

Dabrafenib Plus Trametinib Combination Treats Rare Lung Cancer
Mark L. Fuerst
Free

Dabrafenib Plus Trametinib Improves Survival in Advanced Melanoma
Mark L. Fuerst
Free

Early Palliative Care Improves Outcomes for Family Caregivers
Mark L. Fuerst
Free

Extended AI Therapy in Postmenopausal Women With Early Breast Cancer
Romi Herron-Cologna
Free

Fast-Track Designation for a Treatment for Ewing Sarcoma
Free

First Blood Test to Detect Gene Mutation Associated with NSCLC
Free

From the Trenches: A ‘SWOT’ Analysis of the Practice of Clinical Oncology
Joseph V. Simone MD
Free

Liquid Biopsy May Aid Treatment Decisions in Solid Tumors
Mark L. Fuerst
Free

Liquid Biopsy: ‘Method of the Future’ For Lung Cancer Prediction
Peter M. Goodwin
Free

Ongoing Study Assesses Effectiveness of BBI-608
Catlin Nalley
Free

Online Research Program Enrolls Patients With Breast Cancer
Free

Patient Handout: Talking With Your Children
Wendy Harpham MD, FACP
Free

Precision Medicine to Expand Cancer Therapies
Free

Pre-Treated T790M-Positive Lung Cancer: Osimertinib Benefit Confirmed
Peter M. Goodwin
Free

Primary Tumor Locations Predicts Survival in Colorectal Cancer
Mark L. Fuerst
Free

Racial Disparity in Breast & Ovarian Cancer Risk Management
Free

Shop Talk
Free

Who Leads End-of-Life Discussions Matters, Study Reports
Catlin Nalley
Buy

Chemoradiation & Temozolomide for Patients With Glioblastoma
Romi Herron-Cologna
Buy

Is MRD Negativity Necessary for CLL Patients?
Mark L. Fuerst
Buy

Patient-Driven Model May Accelerate Breast Cancer Research
Mark L. Fuerst
Buy

Patients With Advanced Cancer Choose Aggressive Care Near End of Life

All Issues

Volume : 45

Volume : 44

Volume : 43

Volume : 42

Volume : 41

Volume : 40

Volume : 39

Volume : 38

Volume : 37

Volume : 36

Volume : 35

Volume : 34

Volume : 33

Volume : 32

FIND YOUR NEXT JOB WITH NURSING JOBSPLUS

© 2023 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer -- v08.09.00